Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
Results for
"[search-keyword]"
Sponsor content
432 result(s) found, displaying 301 to 310
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROPIVACAINE KABI ropivacaine hydrochloride 150 mg/20 mL solution for injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROPIVACAINE KABI ropivacaine hydrochloride 100 mg/10 mL solution for injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROPIVACAINE KABI ropivacaine hydrochloride 200 mg/100 mL solution for infusion bag.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROPIVACAINE KABI ropivacaine hydrochloride 400 mg/200 mL solution for infusion bag.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ROPIVACAINE KABI ropivacaine hydrochloride 50 mg/10 mL solution for injection ampoule.
-
Cancellation by sponsorRequested by Fresenius Kabi Australia Pty Ltd
-
Cancellation by sponsorRequested by Fresenius Kabi Australia Pty Ltd
-
Cancellation by sponsorRequested by Fresenius Kabi Australia Pty Ltd
-
Cancellation by sponsorRequested by Fresenius Kabi Australia Pty Ltd
-
Cancellation by sponsorRequested by Fresenius Kabi Australia Pty Ltd